CRL Stock Analysis: Buy, Sell, or Hold?
CRL - Charles River Laboratories International, Inc.
$300.02
-0.13 (-0.04%)
âŧ
5d:
-0.61%
30d:
+7.9%
90d:
+36.75%
WAIT
LOW Confidence
Analysis Updated: Oct 19, 2026 12:00 AM ET
Earnings: Nov 04, 2026
14d
Get Alerted When CRL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CRL is fairly priced but lacks strong directional signals. At 10.2% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CRL is fairly priced but lacks strong directional signals. At 10.2% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$330.06
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$204.94
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CRL is currently trading at $300.02, which is considered slightly high relative to its 30-day fair value range of $280.48 to $302.77. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.5) compared to its historical average (17.6). At these levels, the market is pricing in 10.2% annual earnings growth.
Technical Outlook: Technically, CRL is in a strong uptrend. Immediate support is located at $288.43, while resistance sits at $333.30.
Market Sentiment: CRL scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRL is in a strong uptrend. Immediate support is located at $288.43, while resistance sits at $333.30.
Market Sentiment: CRL scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$280.48 -
$302.77
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.4%
All Signals
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($315.53)
- BULLISH: Expecting earnings turnaround to 10.2% growth with -2.7% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$280.48 -
$302.77
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$288.43
Resistance Level
$333.30
Current Trend
Strong Uptrend
Technical data as of
Oct 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.52
Wall Street Target
$315.53
(+5.2%)
Revenue Growth (YoY)
-2.7%
Earnings Growth (YoY)
-17.3%
Profit Margin
-6.0%
Valuation Premium vs History
+10.2% premium
PE vs Historical
23.5 vs 17.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.2%
(market-implied from PE analysis)
1-Year Target
$330.62
(+10%)
2-Year Target
$364.35
(+21%)
3-Year Target
$401.51
(+34%)
3-Yr Target (if PE normalizes)
(PE: 24â18)
PE COMPRESSION
$300.45
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.5, Growth: 12.1%)
$422.89
(+41%)
Base:
(SPY PE: 19.9, Growth: 12.1%)
$357.09
(+19%)
Bear:
(PE: 16.9, Growth: 12.1%)
$303.53
(+1%)
Share & Embed Analysis
Last updated: October 20, 2026 9:13 AM ET
Data refreshes hourly during market hours. Next update: 10:13 AM
Data refreshes hourly during market hours. Next update: 10:13 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 59 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
28 analysts |
$691 | 43 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 48 HOLD |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
22 analysts |
$299 | 62 BUY |
